^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SY-5933

    i
    Other names: SY-5933, SY5933, SY 5933
    Associations

    News

    Trials
    Company:
    Shouyao Holdings
    Drug class:
    KRAS p.G12C inhibitor
    Associations

    News

    Trials
    10ms
    Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation (clinicaltrials.gov)
    P1/2, N=102, Not yet recruiting, Shouyao Holdings (Beijing) Co. LTD
    New P1/2 trial
    |
    KRAS (KRAS proto-oncogene GTPase)
    |
    KRAS G12C • KRAS G12
    |
    conteltinib (SY-707) • SY-5933
    over2years
    A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation (clinicaltrials.gov)
    P1, N=50, Recruiting, Shouyao Holdings (Beijing) Co. LTD
    New P1 trial • Metastases
    |
    KRAS (KRAS proto-oncogene GTPase)
    |
    KRAS mutation • KRAS G12C • KRAS G12
    |
    SY-5933